Technological advances continue to enhance diagnostics and sequencing capabilities. Qiagen released a long-read target enrichment panel compatible with multiple NGS platforms for detailed genetic variant analysis. Spear Bio introduced ultra-sensitive immunoassays for neurology biomarkers capable of detecting protein targets from minimal sample volumes without wash steps. Zymo Research launched the Endura Tn5 Transposase to improve library preparation stability and reproducibility. Morpho Biotech established a distribution deal for N6 Tec's IconPCR platform in the Benelux region, advancing streamlined NGS sample prep. Additionally, Geneoscopy received FDA approval for an improved stool collection method enhancing colorectal cancer screening compliance.